Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events
Language English Country United States Media print-electronic
Document type Journal Article, Meta-Analysis, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
Grant support
PG/18/50/33837
British Heart Foundation - United Kingdom
PG/18/5033837
British Heart Foundation - United Kingdom
U01 GM074492
NIGMS NIH HHS - United States
Department of Health - United Kingdom
085475/B/08/Z
Wellcome Trust - United Kingdom
P01 HL076491
NHLBI NIH HHS - United States
084727/Z/08/Z
Wellcome Trust - United Kingdom
Medical Research Council - United Kingdom
P50 HL077113
NHLBI NIH HHS - United States
RG/14/5/30893
British Heart Foundation - United Kingdom
072960/Z/03/Z
Wellcome Trust - United Kingdom
085475/Z/08/Z
Wellcome Trust - United Kingdom
R01 NR013396
NINR NIH HHS - United States
FS/14/76/30933
British Heart Foundation - United Kingdom
084726/Z/08/Z
Wellcome Trust - United Kingdom
FS/18/23/33512
British Heart Foundation - United Kingdom
PCL/17/07
Chief Scientist Office - United Kingdom
R01 HL074730
NHLBI NIH HHS - United States
CIHR - Canada
R01 HL133169
NHLBI NIH HHS - United States
PubMed
30897348
PubMed Central
PMC6625876
DOI
10.1161/circgen.119.002471
Knihovny.cz E-resources
- Keywords
- chromosome, genetic, myocardial infarction, risk factor, secondary prevention, variation,
- MeSH
- Gene Frequency MeSH
- Genetic Predisposition to Disease MeSH
- Myocardial Infarction genetics pathology MeSH
- Middle Aged MeSH
- Humans MeSH
- Chromosomes, Human, Pair 9 * MeSH
- Coronary Artery Disease genetics pathology MeSH
- Odds Ratio MeSH
- Risk Factors MeSH
- Case-Control Studies MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Meta-Analysis MeSH
- Research Support, Non-U.S. Gov't MeSH
- Research Support, N.I.H., Extramural MeSH
BACKGROUND: Genetic variation at chromosome 9p21 is a recognized risk factor for coronary heart disease (CHD). However, its effect on disease progression and subsequent events is unclear, raising questions about its value for stratification of residual risk. METHODS: A variant at chromosome 9p21 (rs1333049) was tested for association with subsequent events during follow-up in 103 357 Europeans with established CHD at baseline from the GENIUS-CHD (Genetics of Subsequent Coronary Heart Disease) Consortium (73.1% male, mean age 62.9 years). The primary outcome, subsequent CHD death or myocardial infarction (CHD death/myocardial infarction), occurred in 13 040 of the 93 115 participants with available outcome data. Effect estimates were compared with case/control risk obtained from the CARDIoGRAMplusC4D consortium (Coronary Artery Disease Genome-wide Replication and Meta-analysis [CARDIoGRAM] plus The Coronary Artery Disease [C4D] Genetics) including 47 222 CHD cases and 122 264 controls free of CHD. RESULTS: Meta-analyses revealed no significant association between chromosome 9p21 and the primary outcome of CHD death/myocardial infarction among those with established CHD at baseline (GENIUS-CHD odds ratio, 1.02; 95% CI, 0.99-1.05). This contrasted with a strong association in CARDIoGRAMPlusC4D odds ratio 1.20; 95% CI, 1.18-1.22; P for interaction <0.001 compared with the GENIUS-CHD estimate. Similarly, no clear associations were identified for additional subsequent outcomes, including all-cause death, although we found a modest positive association between chromosome 9p21 and subsequent revascularization (odds ratio, 1.07; 95% CI, 1.04-1.09). CONCLUSIONS: In contrast to studies comparing individuals with CHD to disease-free controls, we found no clear association between genetic variation at chromosome 9p21 and risk of subsequent acute CHD events when all individuals had CHD at baseline. However, the association with subsequent revascularization may support the postulated mechanism of chromosome 9p21 for promoting atheroma development.
5th Department of Medicine Medical Faculty Mannheim Heidelberg University Mannheim Germany
Bart's Heart Centre St Bartholomew's Hospital London United Kingdom
BHF Cardiovascular Research Centre Glenfield Hospital Leicester United Kingdom
CARDIoGRAMPlusC4D University of Groningen University Medical Center Groningen Netherlands
Cardiology Centre Institute for Clinical and Experimental Medicine Prague Czech Republic
Cardiology Department Parma University Hospital Italy
Cardiology Division Department of Internal Medicine
Cardiovascular Research Institute National University of Singapore
Cardiovascular Sciences University of Edinburgh
Centre de recherche de l'Institut Universitaire de cardiologie et de pneumologie de Québec
Centre for Genomic Health Queen Mary University of London
Centro de Pesquisa Clinica Hospital Universitario Universidade de Sao Paulo Brazil
Clinica Mediterranea Naples Italy
Clinical Epidemiology and Biostatistics
Clinical Institute of Medical and Chemical Laboratory Diagnostics Medical University of Graz Austria
CNR Institute of Clinical Physiology Pisa Italy
Departement of Cardiovascular Sciences KU Leuven Belgium
Department of Anesthesia Pain and Critical Care Beth Israel Deaconess Medical Center Boston MA
Department of Anesthesiology Perioperative and Pain Medicine Brigham and Women's Hospital
Department of Biochemistry Microbiology and Immunology
Department of Biomedical Informatics
Department of Biomedical Informatics University of Utah Salt Lake City
Department of Biomedical Sciences Humanitas University Milan Italy
Department of Biostatistics and Epidemiology Texas Heart Institute Houston
Department of Biotechnology Institute of Molecular and Cell Biology University of Tartu Estonia
Department of Cardio Thoracic Surgery
Department of Cardio Thoracic Surgery Heart Center Tampere University Hospital Finland
Department of Cardiology and Internal Diseases Military Institute of Medicine Warsaw Poland
Department of Cardiology Heart Center
Department of Cardiology Leiden University Medical Center
Department of Cardiology Medical University of Warsaw Poland
Department of Cardiovascular Medicine Heart and Vascular Institute and Center for Clinical Genomics
Department of Cardiovascular Medicine Humanitas Clinical and Research Center Milan Italy
Department of Cardiovascular Medicine University of Münster Germany
Department of Cellular and Molecular Medicine Lerner Research Institute
Department of Clinical Chemistry
Department of Clinical Chemistry and Hematology
Department of Clinical Chemistry Fimlab Laboratories Tampere Finland
Department of Clinical Chemistry UMC Utrecht Netherlands
Department of Clinical Physiology
Department of Clinical Sciences Lund University Malmö Sweden
Department of Epidemiology Emory University Rollins School of Public Health
Department of Forensic Medicine Medical University of Bialystok Poland
Department of Genetics Statistical Genomics Division
Department of Internal Medicine Jagiellonian University Medical College Kraków Poland
Department of Internal Medicine Skåne University Hospital Malmö Sweden
Department of Medical Genetics
Department of Medical Sciences Cardiology Uppsala University Sweden
Department of Medical Sciences Clinical Chemistry Uppsala University Sweden
Department of Medicine Cardiovascular Division Washington University School of Medicine St Louis MO
Department of Medicine Faculty of Medicine Université Laval Canada
Department of Medicine University of Verona Italy
Department of Pathology and Molecular Medicine McMaster University
Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics
Department of Population Medicine and Civilization Disease Prevention
Department of Radiology University Medical Center Utrecht the Netherlands
Department of Vascular Medicine Academic Medical Center Amsterdam the Netherlands
Department of Vascular Surgery University Medical Center Utrecht University Utrecht the Netherlands
Departments of Medicine and Biochemistry Microbiology and Immunology University of Ottawa ON Canada
Division Heart and Lungs Department of Cardiology
Division of Cardiology Department of Medicine Royal Victoria Hospital
Division of Cardiovascular Medicine College of Medicine University of Florida
Division of Clinical Epidemiology and Aging Research German Cancer Research Center
Drexel University College of Medicine Philadelphia PA
Durrer Centre of Cardiogenetic Research ICIN Netherlands Heart Institute Netherlands
Einthoven Laboratory for Experimental Vascular Medicine LUMC Leiden
Emeritus Professor of Cardiology University of Edinburgh
Estonian Genome Center Institute of Genomics
Harvard Medical School Boston MA
Heart and Lung Center Helsinki University Hospital University of Helsinki Finland
Heart Health Research Group University of Auckland New Zealand
Heart Institute University of Sao Paulo Brazil
Institute for Genetic Medicine Keck School of Medicine of USC Los Angeles CA
Institute for Medical Informatics Statistics and Epidemiology University of Leipzig Germany
Institute of Cardiovascular and Medical Sciences University of Glasgow United Kingdom
Institute of Cardiovascular Science Faculty of Population Health Science
Institute of Clinical Chemistry and Laboratory Medicine University Hospital Regensburg Germany
Institute of Environmental Medicine Karolinska Institutet Stockholm Sweden
Intermountain Heart Institute Intermountain Medical Center Salt Lake City UT
Interuniversity Cardiology Institute of the Netherlands Utrecht the Netherlands
Julius Center for Health Sciences and Primary Care University Medical Center Utrecht the Netherlands
Laboratory for Translational Genetics Department of Human Genetics
Laboratory for Translational Genetics VIB Center for Cancer Biology VIB Belgium
Laboratory of Experimental Cardiology
LIFE Research Center for Civilization Diseases
Lund University Diabetes Center Lund University Lund Sweden
Medical Central Laboratories Feldkirch Austria
Medical Research Council Population Health Research Unit University of Oxford United Kingdom
National Institute of Health Research Glenfield Hospital Leicester United Kingdom
Population Health Research Institute Hamilton ON Canada
Preventive and Genomic Cardiology McGill University Health Centre Montreal QC Canada
Private University of the Principality of Liechtenstein Triesen Liechtenstein
Research Institute of the McGill University Health Centre
Respiratory Oncology Unit Department of Respiratory Medicine University Hospitals KU Leuven Belgium
Robertson Center for Biostatistics
Ruddy Canadian Cardiovascular Genetics Centre
St Antonius Hospital Department of Cardiology Nieuwegein the Netherlands
Synlab Academy Synlab Holding Deutschland GmbH Mannheim Germany
The Christchurch Heart Institute University of Otago Christchurch New Zealand
Transplantation Laboratory Medicum
Unité d'évaluation cardiovasculaire Institut national d'excellence en santé et en services sociaux
Université de Montréal QC Canada
University of Ottawa Heart Institute
University of Texas School of Public Health Houston
Uppsala Clinical Research Center Uppsala University Sweden
Vorarlberg Institute for Vascular Investigation and Treatment
Wallenberg Center for Molecular Medicine Lund University Lund Sweden
See more in PubMed
Nikpay M, et al. A comprehensive 1,000 genomes-based genome-wide association meta-analysis of coronary artery disease. Nat Genet. 2015;47:1121–1130. doi: 10.1038/ng.3396. PubMed PMC
Helgadottir A, et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science. 2007;316:1491–1493. doi: 10.1126/science.1142842. PubMed
McPherson R, et al. A common allele on chromosome 9 associated with coronary heart disease. Science. 2007;316:1488–1491. doi: 10.1126/science.1142447. PubMed PMC
Samani NJ, et al. WTCCC and the Cardiogenics Consortium. Genomewide association analysis of coronary artery disease. N Engl J Med. 2007;357:443–453. doi: 10.1056/NEJMoa072366. PubMed PMC
Palomaki GE, et al. Association between 9p21 genomic markers and heart disease: a meta-analysis. JAMA. 2010;303:648–656. doi: 10.1001/jama.2010.118. PubMed
Patel RS, et al. Genetic variants at chromosome 9p21 and risk of first versus subsequent coronary heart disease events: a systematic review and meta-analysis. J Am Coll Cardiol. 2014;63:2234–2245. doi: 10.1016/j.jacc.2014.01.065. PubMed PMC
Dehghan A, et al. Genome-wide association study for incident myocardial infarction and coronary heart disease in prospective cohort studies: the CHARGE consortium. PLoS One. 2016;11:e0144997. doi: 10.1371/journal.pone.0144997. PubMed PMC
Patel RS, et al. Subsequent event risk in individuals with established coronary heart disease: design and rationale of the GENIUS-CHD consortium. Circ Genom Precis Med. 2019;12:e002470 PubMed PMC
Genomes Project C, et al. A global reference for human genetic variation. Nature. 2015;526:68–74. PubMed PMC
Ellis KL, et al. A common variant at chromosome 9P21.3 is associated with age of onset of coronary disease but not subsequent mortality. Circ Cardiovasc Genet. 2010;3:286–293. doi: 10.1161/CIRCGENETICS.109.917443. PubMed
Gong Y, et al. Chromosome 9p21 haplotypes and prognosis in white and black patients with coronary artery disease. Circ Cardiovasc Genet. 2011;4:169–178. doi: 10.1161/CIRCGENETICS.110.959296. PubMed PMC
Horne BD, et al. Association of variation in the chromosome 9p21 locus with myocardial infarction versus chronic coronary artery disease. Circ Cardiovasc Genet. 2008;1:85–92. doi: 10.1161/CIRCGENETICS.108.793158. PubMed PMC
Virani SS, et al. Chromosome 9p21 single nucleotide polymorphisms are not associated with recurrent myocardial infarction in patients with established coronary artery disease. Circ J. 2012;76:950–956. PubMed PMC
Wauters E, et al. Influence of 23 coronary artery disease variants on recurrent myocardial infarction or cardiac death: the GRACE Genetics Study. Eur Heart J. 2013;34:993–1001. doi: 10.1093/eurheartj/ehs389. PubMed
Dahabreh IJ, et al. Index event bias as an explanation for the paradoxes of recurrence risk research. JAMA. 2011;305:822–823. doi: 10.1001/jama.2011.163. PubMed PMC
Cole SR, et al. Illustrating bias due to conditioning on a collider. Int J Epidemiol. 2010;39:417–420. doi: 10.1093/ije/dyp334. PubMed PMC
Anderson CD, et al. The effect of survival bias on case-control genetic association studies of highly lethal diseases. Circ Cardiovasc Genet. 2011;4:188–196. doi: 10.1161/CIRCGENETICS.110.957928. PubMed PMC
Hu YJ, et al. Impact of selection bias on estimation of subsequent event risk. Circ Cardiovasc Genet. 2017;10 PubMed PMC
Falk E, et al. Update on acute coronary syndromes: the pathologists’ view. Eur Heart J. 2013;34:719–728. doi: 10.1093/eurheartj/ehs411. PubMed
Reilly MP, et al. Myocardial Infarction Genetics Consortium; Wellcome Trust Case Control Consortium. Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies. Lancet. 2011;377:383–392. doi: 10.1016/S0140-6736(10)61996-4. PubMed PMC
Chan K, et al. Association between the chromosome 9p21 locus and angiographic coronary artery disease burden: a collaborative meta-analysis. J Am Coll Cardiol. 2013;61:957–970. doi: 10.1016/j.jacc.2012.10.051. PubMed PMC
Visel A, et al. Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice. Nature. 2010;464:409–412. doi: 10.1038/nature08801. PubMed PMC